Aytu Biopharma (AYTU) Return on Equity [ROE] (2015 - 2026)
Aytu Biopharma (AYTU) posted Return on Equity [ROE] of -40.48% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 9.88 percentage points from -50.36% a year earlier and up 97.55 percentage points from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma's Return on Equity [ROE] came in at -52.55%, up 5.55 percentage points from FY2025.
- Annual Return on Equity [ROE] shows a five-year change of -2.43 percentage points (FY2021 to FY2026).
- In prior fiscal years, Aytu Biopharma's Return on Equity [ROE] was -58.10% in FY2025 (-10.86 pp), -47.24% in FY2024 (-6.48 pp), -40.76% in FY2023 (+78.86 pp) and -119.62% in FY2022 (-69.50 pp).
- The fiscal Q4 2026 figure stands as the highest quarterly Return on Equity [ROE] since fiscal Q3 2025.
- On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of -18.80 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was fiscal Q4 2023, with a gain of 163.83 percentage points; the weakest was fiscal Q4 2022, with a drop of 164.97 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior fiscal quarters was -138.03% (Q3 2026), -130.81% (Q2 2026) and -62.04% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn | -40.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.48% |
| Mar 31, 2026 | -138.03% |
| Dec 31, 2025 | -130.81% |
| Sep 30, 2025 | -62.04% |
| Jun 30, 2025 | -50.36% |
| Mar 31, 2025 | 4.99% |
| Dec 31, 2024 | -17.30% |
| Sep 30, 2024 | -21.72% |
| Jun 30, 2024 | -54.17% |
| Mar 31, 2024 | -43.01% |
| Dec 31, 2023 | -55.36% |
| Sep 30, 2023 | -68.42% |
| Jun 30, 2023 | -42.48% |
| Mar 31, 2023 | -70.76% |
| Dec 31, 2022 | -163.06% |
| Sep 30, 2022 | -176.20% |
| Jun 30, 2022 | -206.31% |
| Mar 31, 2022 | -133.70% |
| Dec 31, 2021 | -77.04% |
| Sep 30, 2021 | -65.50% |
API Access
Aytu Biopharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();